N Mirzakhmedova
The World Health Organization estimates that more than a billion people on the planet are overweight or obese. At the same time, in the countries of Western Europe from 20–25%
women are obese. A feature of obesity is that it is often combined with serious diseases that lead to a reduction in the life expectancy of patients: with type 2 diabetes mellitus, arterial hypertension, dyslipidemia, atherosclerosis, coronary heart disease, sleep apnea syndrome, some types of malignant neo-formations, reproductive disorders, diseases of the musculoskeletal system. But the most important aspect of the problem of obesity is its relationship with type 2 diabetes mellitus. The risk of developing type 2 diabetes mellitus (T2DM) is significantly increased
is directly proportional to the body mass index and the severity of dyslipidemia. Currently, the number of patients with diabetes is 177 million people, and 90% of patients are patients with type 2 diabetes. Almost over the past 20 years, the number of patients with diabetes in the world has increased by 6 times. By 2020In 2009, the number of patients is projected to increase to 300 million people. It should be noted that women over 45 suffer from DM twice as often as men [1, 2].
